Tyers Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Tyers Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.34M	Sell	4,816 -64	-1%	-$18.9K	0.04%	291
2019 Q2	$1.53M	Sell	4,880 -4,032	-45%	-$1.34M	0.05%	262
2019 Q1	$3.66M	Buy	8,912 +6,000	+206%	+$2.47M	0.13%	146
2018 Q4	$1.09M	Buy	2,912 +784	+37%	+$287K	0.04%	270
2018 Q3	$860K	Buy	2,128 +480	+29%	+$183K	0.03%	328
2018 Q2	$569K	Buy	1,648 +32	+2%	+$10K	0.02%	401
2018 Q1	$556K	Sell	1,616 -272	-14%	-$94.6K	0.02%	395
2017 Q4	$710K	Buy	1,888 +880	+87%	+$356K	0.02%	348
2017 Q3	$451K	Sell	1,008 -48	-5%	-$22.8K	0.02%	432
2017 Q2	$519K	Sell	1,056 -112	-10%	-$49K	0.02%	400
2017 Q1	$453K	Sell	1,168 -16	-1%	-$5.93K	0.02%	411
2016 Q4	$435K	Buy	+1,184	New	+$450K	0.02%	377

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Tyers Asset Management's REGN Position: Q3 2019 in Review

Tyers Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 1.3% in Q3 2019, selling an estimated $18.9K and leaving 4,816 shares worth $1.34M. The position accounts for 0.04% of the portfolio, ranked #291.

Tyers Asset Management first reported a position in REGN in Q4 2016 and has held it in 12 quarters since. The position peaked at $3.66M in Q1 2019. 633 funds tracked by Wall St. Rank hold REGN as of Q3 2019.

Tyers Asset Management held 4,816 shares of Regeneron Pharmaceuticals worth $1.34M as of Q3 2019.
Tyers Asset Management sold 64 Regeneron Pharmaceuticals shares in Q3 2019, an estimated $18.9K.
Regeneron Pharmaceuticals made up 0.04% of Tyers Asset Management's portfolio in Q3 2019, its #291 holding.
Tyers Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2016 and has held it in 12 quarters since.
Tyers Asset Management's Regeneron Pharmaceuticals position peaked at $3.66M in Q1 2019.
633 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.